AU2005335661A1 - Novel 4-amino-thieno[3,2-C]pyridine-7-carboxylic acid amides - Google Patents

Novel 4-amino-thieno[3,2-C]pyridine-7-carboxylic acid amides Download PDF

Info

Publication number
AU2005335661A1
AU2005335661A1 AU2005335661A AU2005335661A AU2005335661A1 AU 2005335661 A1 AU2005335661 A1 AU 2005335661A1 AU 2005335661 A AU2005335661 A AU 2005335661A AU 2005335661 A AU2005335661 A AU 2005335661A AU 2005335661 A1 AU2005335661 A1 AU 2005335661A1
Authority
AU
Australia
Prior art keywords
substituted
lower alkyl
heterocycle
pyridine
thieno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005335661A
Other languages
English (en)
Inventor
Kin-Chun Luk
Lee Apostle Mcdermott
Pamela Loreen Rossman
Peter Michael Wovkulich
Zhuming Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU2005335661A1 publication Critical patent/AU2005335661A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2005335661A 2005-08-16 2005-08-16 Novel 4-amino-thieno[3,2-C]pyridine-7-carboxylic acid amides Abandoned AU2005335661A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2005/054022 WO2007019884A1 (fr) 2005-08-16 2005-08-16 Nouveaux amides de l'acide 4-amino-thiéno[3,2-c]pyridine-7-carboxylique

Publications (1)

Publication Number Publication Date
AU2005335661A1 true AU2005335661A1 (en) 2007-02-22

Family

ID=35159670

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005335661A Abandoned AU2005335661A1 (en) 2005-08-16 2005-08-16 Novel 4-amino-thieno[3,2-C]pyridine-7-carboxylic acid amides

Country Status (9)

Country Link
EP (1) EP1917015A1 (fr)
JP (1) JP2009504692A (fr)
KR (1) KR100995790B1 (fr)
AU (1) AU2005335661A1 (fr)
BR (1) BRPI0520482A2 (fr)
CA (1) CA2619459A1 (fr)
IL (1) IL189181A0 (fr)
MX (1) MX2008002060A (fr)
WO (1) WO2007019884A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006290802B2 (en) * 2005-09-15 2012-06-07 F. Hoffmann-La Roche Ag 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR070317A1 (es) * 2008-02-06 2010-03-31 Osi Pharm Inc Furo (3,2-c) piridina y tieno (3,2-c) piridinas
US20120189641A1 (en) 2009-02-25 2012-07-26 OSI Pharmaceuticals, LLC Combination anti-cancer therapy
US8642834B2 (en) 2009-02-27 2014-02-04 OSI Pharmaceuticals, LLC Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
WO2010099138A2 (fr) 2009-02-27 2010-09-02 Osi Pharmaceuticals, Inc. Procédés pour l'identification d'agents qui inhibent les cellules tumorales de type mésenchymateuses ou leur formation
US9896730B2 (en) 2011-04-25 2018-02-20 OSI Pharmaceuticals, LLC Use of EMT gene signatures in cancer drug discovery, diagnostics, and treatment
WO2013152252A1 (fr) 2012-04-06 2013-10-10 OSI Pharmaceuticals, LLC Polythérapie antinéoplasique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232320B1 (en) * 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
CA2502429A1 (fr) * 2002-10-31 2004-05-21 Amgen Inc. Agents anti-inflammatoires
JP2006528685A (ja) * 2003-05-06 2006-12-21 スミスクライン ビーチャム コーポレーション 新規化合物
US20050020619A1 (en) * 2003-07-24 2005-01-27 Patrick Betschmann Thienopyridine kinase inhibitors
US20050026944A1 (en) * 2003-07-24 2005-02-03 Patrick Betschmann Thienopyridine and furopyridine kinase inhibitors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006290802B2 (en) * 2005-09-15 2012-06-07 F. Hoffmann-La Roche Ag 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives

Also Published As

Publication number Publication date
CA2619459A1 (fr) 2007-02-22
IL189181A0 (en) 2008-06-05
EP1917015A1 (fr) 2008-05-07
WO2007019884A1 (fr) 2007-02-22
BRPI0520482A2 (pt) 2009-05-12
KR20080027945A (ko) 2008-03-28
MX2008002060A (es) 2008-04-16
KR100995790B1 (ko) 2010-11-22
JP2009504692A (ja) 2009-02-05

Similar Documents

Publication Publication Date Title
US20050256154A1 (en) 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid amides
CA2621830C (fr) Derives d'acide 4-amino-thieno[3,2-c]pyridine-7-carboxylique
AU2008302099B2 (en) Substituted amides, methods of making, use thereof for the treatment of diseases such as cancer
US7592352B2 (en) Substituted thieno and furo-pyridines
US7084270B2 (en) Pyrimido compounds having antiproliferative activity
CN102713618A (zh) 蛋白激酶复合物和抑制剂
AU2005335661A1 (en) Novel 4-amino-thieno[3,2-C]pyridine-7-carboxylic acid amides
AU2008237717A1 (en) 2-morpholin-4-yl-pyrimidines as PI3K inhibitors
JP5583698B2 (ja) プロテインキナーゼａｂｌおよびｓｒｃの阻害剤としてのアザインドール誘導体
MX2008015904A (es) Inhibidores de akt (proteina cinasa b).
WO2019154395A1 (fr) Composé de tétrahydroisoquinoléine, son procédé de préparation, composition pharmaceutique le contenant et utilisation associée
EP1819669A2 (fr) Nouveaux inhibiteurs de l'histone deacetylase permettant de traiter une maladie
CN115353508A (zh) 5-吡啶-1h-吲唑类化合物、药物组合物和应用
WO2022148243A1 (fr) Composé de pyrimidine à petites molécules et son application
CN116496219A (zh) 六元并五元杂环类化合物及其药物组合物和应用
CN110305125B (zh) 5-嘧啶-6-氧-吡唑并吡啶类衍生物及其制备方法和应用
KR20110020784A (ko) Ｉｋｋ-베타 세린-트레오닌 단백질 키나아제의 억제제
CN114437113B (zh) 一种噻唑并吡啶环联三氮唑类化合物及其制备方法和应用
CN115197167A (zh) 1,2,4-噻二唑烷-3,5-二酮化合物及其制备方法和应用
CN117069698B (zh) 靶向shp2降解的双功能分子及其制备和应用
CN108047132A (zh) 二苯胺基吡啶类抗肿瘤化合物及其制备方法与用途
CN110229146B (zh) 组蛋白去乙酰化酶抑制剂及其制备方法与用途
KR100468352B1 (ko) 신규 피라졸로피리미딘계 유도체, 그의 제조방법 및 이를 유효성분으로 하는 약학적 조성물
CN118184677A (zh) 一类用于治疗神经内分泌肿瘤的pld3激动剂及其制备方法、应用
CN118184572A (zh) 一类新型HsClpP激动剂的制备及其在抗炎抗肿瘤中的用途

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application